Dexcom is an APPLE specific device . . . DRIO is Android-based.
Ask yourself who has most of regular folks phone market worldwide . . . its Android.
Cost-to-use: DRIO hands down . . . Amazon says $300+ / Dexcom device and it has higher priced test probes. Dexcom uses sub-Q skin probe that can be used up to 7 days safely.
I do not like the idea of having a diabetic patient with an installed sub-Q insert area on the skin. Sounds like infection central station for skin problems.
DRIO also has said it can use its technology, to develop testing for 'other bodily fluids' . . . can Dexcom?
Compare Apple to Android . . . who has most money?
Which company has highest R&D budget?
Many companies are eating APPLE, as each of them chips away at its silly high-pricing points, for its retail and business products.
Total up the competitive companies R&D fundings and staffs, Apple is facing huge competitive forces that will out-innovate it and out-spend it. Each competitor is taking aim at a specific part of Apple's present and future product lines.
Apple is basically a dying company, with high-end narrow customer base . . . Android/DRIO is my bet in the new economy. Also note, that Elon Musk (tesla) has obtained funding from Goggle for a new form of world-wide, satellite-based internet.
Most of world (like us) are getting poorer, not richer.
Even mighty MSFT, is now having to bow to Android market share marketing . . . witness MSFT to give away Windows 10 to its customers.
Dexcom is a private company.
We own a public stock company.
All we are waiting for is DRIO, to approach Goggle and talk shop.
Goggle just has to make a few phone calls and FDA will roll-over.
Goggle is the super-bowl champion in mobile electronics: and they do not need to use deflated balls.
Mobile health readers IS MAJOR way to improve efficiency and cost-structure of Health Care favorably, for everyone involved.
